A non-invasive liquid biopsy diagnostic test for early-stage prostate cancer detection based on glycan analysis in blood serum. The test uses antibody-coated magnetic particles to detect cancer biomarkers from a minimal blood sample (10 µL or less than a single blood drop) with up to 90% accuracy. I...
Manufactured by
Glycanostics, s.r.o.
Bratislava, Slovakia
At Glycanostics, our aim is to develop, clinically validate register an affordable, non-invasive next-gen liquid biopsy prostate cancer diagnostic test with accuracy of up to 90%.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Berkeley Health Ltd
United Kingdom · 2 relevant products
Biomerica, Inc.
United States · 2 relevant products
Zhejiang QL Biotech Co., Ltd.
China · 1 relevant product
63 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →16 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 99 closest product alternatives
Berkeley Health Ltd · United Kingdom
Rapid home test kit for semi-quantitative detection of prostate-specific antigen in human whole blood. Enables self-screening for prostate health status with results available within 15 minutes. ISO 13485:2016 certified for accuracy and reliability.
Biomerica, Inc. · United States
An advanced diagnostic test for prostate cancer screening. Designed as an at-home screening product targeting high-prevalence cancer detection.
Berkeley Health Ltd · United Kingdom
Rapid self-test kit for prostate PSA screening enabling home-based detection and early identification of prostate health concerns. The test delivers accurate results comparable to clinical laboratory analysis with simple instructions and quick turnaround. ISO 13485:2016 certified in-vitro diagnostic device designed for patient convenience and accessibility.
96 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products